Wednesday, June 9, 2021 (HealthDay News)
Platelets are blood cells that help prevent blood loss when blood vessels are damaged. Low platelet levels may be asymptomatic, but they may increase the risk of bleeding and coagulation.
Researchers have found that two weeks after vaccination with the AstraZeneca vaccine, ITP may increase slightly, potentially increasing the risk of arterial coagulation and bleeding events.
AstraZeneca vaccine is not approved for use in the United States. There was no evidence of increased risk of ITP, coagulation or bleeding with the Pfizer-BioNTech vaccine.No other COVID-19 (New Coronavirus Infection) vaccine Included in a study published online June 9 in the journal Nature medicine..
“This careful analysis of national vaccination programs, including studies of more than 2.5 million first doses. vaccineFound a slight increase in the risk of ITP, coagulation, and bleeding events after Oxford-AstraZeneca vaccination, “said Azizshake, director of the University of Edinburgh Asher Institute, co-author of the study. I am.
“Reassuringly, patients vaccinated with the Pfizer-BioNTech mRNA vaccine were not found to have an overall increased risk of ITP, coagulation, and bleeding. The vaccine program has been extended to young and healthy individuals. Therefore, we plan to update the analysis. vaccine The lead author of the study, Professor Colin Simpson of Victoria University of Wellington, New Zealand, said.
For more information
The National Institutes of Health ITP.
Source: University of Edinburgh, News Release, June 9, 2021
Copyright © 2021 Health Day. all rights reserved.